Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution.

ABSTRACT:

Background

The impact of COVID-19 has been felt in every field of medicine. We sought to understand how lung cancer surgery was affected at a high volume institution. We hypothesized that patients would wait longer for surgery, have more advanced tumors, and experience more complications during the COVID-19 crisis.

Methods

A retrospective review was conducted, comparing pathologically confirmed non-small cell lung cancer (NSCLC) surgical cases performed in 2019 to cases performed from March to May 2020, during the height of the COVID-19 crisis. Clinical and pathologic stage, tumor size, time to surgery, follow up time, and complications were evaluated.

Results

A total of 375 cases were performed in 2019 vs. 58 cases in March to May 2020. Overall, there were no

SUBMITTER: Dolan DP 

PROVIDER: S-EPMC9442535 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature